Why vaccine development relies on philanthropy [FT.com - Mergermarket]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: FT.com - Mergermarket
Sarah MurrayMay 22, 2020Print this pageBe the first to know about every new storyWith long time horizons, complex science and high failure rates, vaccine development is not for the faint-hearted philanthropist. But in a world gripped by coronavirus, many donors have put aside such concerns and are writing large cheques in the hope of contributing to the end of the pandemic.Alibaba founder Jack Ma has promised more than $14m for coronavirus research, while the Bill & Melinda Gates Foundation has pledged up to $100m to the global response to Covid-19, including funding to accelerate the development of vaccines.Even the Gates Foundation’s move pales in comparison with the funds now being committed by governments and pharmaceutical companies. In the alone, the National Institutes of , the federal research centres, have secured $1.8bn in additional government funding for Covid-19 work, including vaccine investigations.Meanwhile the American drugs group Johnson & Johnson is putting $1bn in
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- PBIRx Growth Fueled by Johnson & Johnson ERISA Lawsuit [Yahoo! Finance]Yahoo! Finance
- Neurocrine Biosciences upgraded at Wells Fargo on pipeline [Seeking Alpha]Seeking Alpha
- What's in Store for These 5 Pharma Bigwigs in Q1 Earnings? [Yahoo! Finance]Yahoo! Finance
- Prevent Blindness Declares May as First-ever Inherited Retinal Disease (IRD) Genetic Testing Awareness Month [Yahoo! Finance]Yahoo! Finance
- Prevent Blindness Declares May as First-ever Inherited Retinal Disease (IRD) Genetic Testing Awareness MonthPR Web
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website